Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 01 Mar 2023
United States: According to a recent study published in Science Advances, the first small stretch elastic bandage heals.
Read Full NewsThe pediatric epileptologist at Boston Children’s Hospital discussed national variability in treating infantile epileptic spasms syndrome and the evidence gaps that continue to shape clinical decision making.
Charles Bernick, MD, a staff neurologist at the Cleveland Clinic Lou Ruvo Center for Brain Health, commented on the scientific rationale, therapeutic strategies, and biomarker advances driving the next wave of anti-tau drug development in Alzheimer disease.
Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO
1.
The White House has postponed its plan to outlaw menthol cigarettes indefinitely.
2.
Recent research suggests that vitamin supplements may increase the risk of developing cancer.
3.
Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.
4.
Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.
5.
Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery
1.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
2.
Examining Serum Osmolality: What It Is And How To Test For It
3.
Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends
4.
Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies
5.
Bridging the Global Divide: Enhancing Psychosocial Care for Cancer Survivors Across Income Settings
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge